|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
A sentrant sheath was used as a conduit during the implant of a transcatheter valve.It was reported during the procedure, the sentrant sheath was used before the delivery system was introduced.The valve was implanted as planned.It was noted after the release of the prosthesis, the patients¿ blood pressure dropped and through the echocardiogram images a pericardial effusion was identified, it was suspected a guide wire injured the pericardium.A puncture for drainage was performed, after managing to stabilize the patient's hemodynamic condition and the patient underwent an intervention for septal closure.On the 14-dec-2023.The patient condition deteriorated and the patient passed away.Per the physician the sentrant sheath did not cause any harm to the patient.No additional clinical sequalae were provided and the patient expired.
|